SCHEMBL20202079

SCHEMBL20202079

COCCCCOC(=O)CCCCC(=O)OCCCCOC(=O)c1ccccn1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.55
ALDH1A1 P00352 6/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
PKM P14618 1/20 0.48
L3MBTL1 Q9Y468 5/20 0.47
KDM4E B2RXH2 3/20 0.47
HTT P42858 1/20 0.47
KDM4C Q9H3R0 1/20 0.47
GAA P10253 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
TSHR P16473 1/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
KMT2A Q03164 1/20 0.41
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1269440 0.80 APP (0.63) APPALDH1A1SMN1; SMN2PKML3MBTL1
SCHEMBL20202081 0.80 KMT2A (0.42) APPALDH1A1SMN1; SMN2L3MBTL1KDM4E
SCHEMBL28038535 0.79 APP (0.61) APPALDH1A1SMN1; SMN2PKML3MBTL1
Calcium SCHEMBL2689056 0.79 APP (0.61) APPALDH1A1SMN1; SMN2PKML3MBTL1
SCHEMBL27684582 0.79 LMNA (0.62) APPALDH1A1SMN1; SMN2PKML3MBTL1
SCHEMBL11148883 0.79 LMNA (0.62) APPALDH1A1SMN1; SMN2PKML3MBTL1
SCHEMBL5935797 0.79 LMNA (0.62) APPALDH1A1SMN1; SMN2PKML3MBTL1
SCHEMBL27665123 0.79 ALDH1A1 (0.58) APPALDH1A1SMN1; SMN2PKML3MBTL1
SCHEMBL29184950 0.79 LMNA (0.62) APPALDH1A1SMN1; SMN2PKML3MBTL1
SCHEMBL4770615 0.79 APP (0.55) APPALDH1A1SMN1; SMN2PKML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807886-B2 Process for the preparation of copolymers derived from 2,4- or 2,5-pyridinedicarboxylic acid BIOME BIOPLASTICS LIMITED (GB) 2023-11-07 US disclosed
US-20180148752-A1 PROCESS FOR THE PREPARATION OF 2,4- OR 2,5-PYRIDINEDICARBOXYLIC ACID AND COPOLYMERS DERIVED THEREFROM BIOME BIOPLASTICS LIMITED (GB) 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11807886-B2 Process for the preparation of copolymers derived from 2,4- or 2,5-pyridinedicarboxylic acid HPD, PGD, PCCA APP 2703/4885ALDH1A1 326/4885SMN1; SMN2 4484/4885
US-20180148752-A1 PROCESS FOR THE PREPARATION OF 2,4- OR 2,5-PYRIDINEDICARBOXYLIC ACID AND COPOLYMERS DERIVED THEREFROM HPD, PCCA, MVD APP 2971/4885ALDH1A1 308/4885SMN1; SMN2 4593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.